Menu Search
Equities

LifeTech Scientific Corp

1302:HKG.HS

LifeTech Scientific Corp

Actions
  • Price (HKD)1.74
  • Today's Change0.04 / 2.35%
  • Shares traded4.01m
  • 1 Year change-35.07%
  • Beta--
Data delayed at least 15 minutes, as of May 06 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

LifeTech Scientific Corporation is an investment holding company principally engaged in the manufacturing and marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.

  • Revenue in HKD (TTM)1.37bn
  • Net income in HKD283.98m
  • Incorporated2006
  • Employees1.45k
  • Location
    LifeTech Scientific CorpCybio Electronic BuildingLangshn 2nd St,North Ar of Hgh-tch PrkNanshan DistrictSHENZHEN 518063ChinaCHN
  • Phone+86 75 586026250
  • Websitehttp://www.lifetechmed.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.